Immunotherapy
Cure8 research brief
Why This Matters
If you have MS and another autoimmune disease, your neurologist may choose different disease-modifying therapies. The study found higher-than-expected rates of rheumatoid arthritis and IBD among Indian MS patients and corresponding shifts in treatment choices.
Who Should Pay Attention
Neurologists and MS clinicians; researchers in autoimmune diseases; adults with MS and coexisting autoimmune conditions (including IBD).
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The study suggests clinicians may alter MS disease-modifying therapy choices when patients have other autoimmune conditions, including IBD. It does not provide treatment efficacy comparisons or clinical guidance for IBD management; it reports associations observed in this cohort.
Keep In Mind
Cross-sectional observational data from Indian clinics (2016–2026); findings show associations, not causation. The summary is based on the article abstract.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationImmunotherapy
AuthorsAliakbar Netterwala, Surabhi Garg, Pritam Majumdar +14 more
InstitutionDepartment of Neurology, St. John's Medical College Hospital, Bengaluru, India.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedNov 9, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Inflammatory Bowel Disease Is Associated With an Increased Risk of End-Stage Renal Disease: A Population-Based Cohort Study.
If you have IBD — especially Crohn’s — this study suggests your long-term risk of needing dialysis or a kidney transplant may be higher than the general population. Certain treatments and prior bowel surgery were linked...
IBD Associated With Risk for Genitourinary Cancers
A pooled analysis presented at a medical conference suggests people with IBD—especially ulcerative colitis—may have higher rates of some genitourinary cancers, which could affect discussions about cancer risk and...
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Serious infections in patients with inflammatory bowel disease and corticosteroids: A propensity score-matched study.
Corticosteroid use during IBD treatment periods was associated with higher rates of serious infections across drug classes and age groups, which may affect decisions about steroid use and infection-prevention planning.